Newsroom | 1635 results

LOS ANGELES--(BUSINESS WIRE)--As the pharmaceutical industry gathers for the Global Pharma & Biotech Summit in London this week, AIDS Healthcare Foundation (AHF) is launching a mobile billboard that will circle the venue (Convene 22 Bishopsgate) on Nov. 11-12 to spotlight Gilead Sciences’ greed and refusal to make its breakthrough HIV prevention drug lenacapavir truly affordable and accessible. The roving billboard carries an urgent demand to Gilead and its CEO Daniel O’Day to “Make Lenacap...

CHAPEL HILL, N.C. & TORONTO & LONDON & ZUG, Switzerland--(BUSINESS WIRE)--AESARA, a leading digital-forward Value & Access agency, today announced the appointment of Jennifer Cain Birkmose as VP, Strategic Partnerships, Europe. With over 20 years of experience spanning healthcare, biotechnology, and pharmaceuticals, Jennifer brings deep expertise in innovative access strategies, global health partnerships, and policy leadership that will strengthen AESARA’s mission to advance value-driven a...

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--Jamaica: AHF Charters Miami Flight to Deploy Critical Hurricane Relief...

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced it has been awarded the prestigious 2025 Prix Galien USA Award for Best Pharmaceutical Product for Yeztugo® (lenacapavir), the company’s twice-yearly injectable HIV-1 capsid inhibitor that provides adults and adolescents (≥35kg) at risk of HIV-1 acquisition with a new, highly effective option for pre-exposure prophylaxis (PrEP) for the prevention of HIV. The award, which recognizes outstanding pharmaceuti...

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) announced today its third quarter 2025 results of operations. “We continue to deliver on Gilead's robust portfolio with a strong start for Yeztugo, rapidly growing uptake of Biktarvy, Descovy and Livdelzi, and positive data for Trodelvy in 1L metastatic triple negative breast cancer,” said Daniel O’Day, Gilead’s Chairman and Chief Executive Officer. “With multiple potential product launches in 2026, the strongest clinica...

WASHINGTON--(BUSINESS WIRE)--Victory! AHF, 100 Organizations Kill Gilead’s Greedy Drug Price Hikes...

MIAMI--(BUSINESS WIRE)--AIDS Healthcare Foundation (AHF), in collaboration with the University of Miami Public Health Policy Lab, will cohost a webinar, “Equity on the Line: The PABS Annex and the Future of the Pandemic Agreement,” on Wednesday, October 29, 2025 at 10:00 AM EDT, virtually via Zoom. Register here. The Intergovernmental Working Group (IGWG) on the WHO Pandemic Agreement has entered a decisive phase, with Member States facing a compressed timeline to finalize the Pathogen Access a...

MENLO PARK, Calif.--(BUSINESS WIRE)--As millions of Americans track sleep and heart rate variability through wearable devices, ProDx Health is addressing the question those devices can't answer: what's actually causing the data to change. The Menlo Park-based diagnostic laboratory today announced its hormone testing service is now available nationwide, delivering testosterone, cortisol, and thyroid results in 48 hours – a significant improvement over the 7-10 day turnaround typical of tradition...

MIAMI--(BUSINESS WIRE)--AIDS Healthcare Foundation (AHF), in collaboration with the University of Miami Public Health Policy Lab, will cohost a webinar, “Antimicrobial Resistance – A Global Health Security Crisis,” on Thursday, October 23, 2025 at 10:00 AM EDT, virtually via Zoom. Register here. This timely webinar will confront one of the most urgent yet underestimated threats to global health: antimicrobial resistance (AMR). Responsible for nearly five million deaths each year, AMR jeopardize...

WASHINGTON--(BUSINESS WIRE)--AHF: 80 Organizations Denounce Gilead on Price Hikes Gutting ADAP...